DoD Military Burn, Technology/Therapeutic Development Award
ID: 353616Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Procurement Contract

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353616
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 18, 2024 12:00 AM
  4. 4
    Due Sep 9, 2024 12:00 AM
Description

The Department of the Army -- USAMRAA has posted a federal grant notice titled "DoD Military Burn, Technology/Therapeutic Development Award". This procurement contract falls under the category of Science and Technology and other Research and Development. The grant does not require cost sharing or matching. The grant aims to support the translation of promising preclinical findings into products for clinical application in resource-limited settings, particularly within the pre-hospital or early acute phase of care environments. The grant is open to unrestricted applicants. The close date for applications is September 9, 2024. The estimated total program funding is $4,400,000, and it is expected that two awards will be granted. The grant is focused on the development of products that address the needs of military Service Members, Veterans, their beneficiaries, and the American public. The products to be developed may include tangible items such as medical devices or pharmacologic agents, as well as knowledge products applicable to technology or therapeutic development. The proposed product must have achieved a minimum technology readiness level (TRL) or knowledge readiness level (KRL) of 3 at the time of pre-application submission. Proof-of-concept and a prototype/preliminary version of the proposed product must also be established at the time of pre-application submission. The grant does not support clinical trials or clinical research studies, but rather research that is supported by significant preliminary data and aims to advance to the level of clinical use. Collaboration with academia, industry, the military Services, the Department of Veterans Affairs (VA), and other federal government agencies is encouraged. The funding instrument for awards made under this program announcement will be assistance agreements, contracts, or Other Transactions. The anticipated total costs budgeted for the entire period of performance should not exceed $2,200,000.

Point(s) of Contact
help@eBRAP.org
Files
Title
Posted
HT942524SMBRP-TTDA-BAA_GG.pdf
4/19/2024
Similar Opportunities
DoD Military Burn, Patient-Centered Research Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a grant opportunity titled "DoD Military Burn, Patient-Centered Research Award". This grant aims to bridge the gap between research, practice, and policy by building a knowledge base that provides clinically useful findings about how interventions, clinical practices/guidelines, tools, and policies can be deployed to targeted populations at the appropriate time at the point of need. The funding from this grant must support clinical research or clinical trials but cannot be used for preclinical or animal research. The grant may support studies focusing on research that accelerates the uptake and implementation of evidence-based research into clinical practice, comparative effectiveness research, development and evaluation of strategies to overcome barriers to the adoption of evidence-based interventions, analysis of existing clinical data, modification of established clinical tools, analysis of burn outcomes associated with the implementation of clinical practice guidelines, and more. The grant expects to fund approximately two applications with a total budget not exceeding $2.2 million. The deadline for application submission is September 9, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
DoD Joint Warfighter Medical, Military Medical Research and Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a federal grant opportunity titled "DoD Joint Warfighter Medical, Military Medical Research and Development Award". This procurement contract falls under the category of Science and Technology and other Research and Development. The grant does not require cost sharing or matching. The estimated total program funding for this opportunity is $7,400,000, with an expected number of 3 awards to be granted. The purpose of this grant is to fund the continuation of previously DOD-funded research or development efforts that are relevant to the FY24 JWMRP Focus Areas. The aim is to accelerate and augment the development of medical products and healthcare solutions for active-duty Service Members, their Families, Veterans, and/or the American public. Collaboration with DOD organizations is encouraged, and applications/proposals from small businesses and partnerships with industry are also welcomed. The MMRDA mechanism supports a wide range of research projects, including late-stage preclinical studies, late-stage technology development efforts, technology demonstration, and translational research. Additionally, there is a Clinical Research or Clinical Trial Option available to support clinical research/observational studies, all phases of clinical trials/interventional studies, and correlative studies for the development of promising pharmaceutical or biologic candidates, medical devices, and technologies. Applicants are encouraged to collaborate with DOD organizations when it contributes to the success of the research effort. If any funds are designated for DOD laboratories or activities, they should be identified in the application/proposal through the submission of a "Suggested Intragovernmental/Intramural Budget Form," Attachment 15. Applicants are also required to submit additional relevant application/proposal materials if applying under the Clinical Research or Clinical Trial Option. The close date for this grant opportunity is August 29, 2024, and the archive date is September 28, 2024. For any inquiries or assistance, applicants can contact the CDMRP Help Desk via phone at 301-682-5507 or email at help@eBRAP.org.
DoD Combat Readiness - Medical, Translational Research Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a federal grant notice titled "DoD Combat Readiness - Medical, Translational Research Award." This grant opportunity falls under the category of Science and Technology and other Research and Development. The purpose of this grant is to support high-impact translational research that will accelerate innovative ideas into clinical applications, including health care products, technologies, and/or practice guidelines. The research funded under this award mechanism should be hypothesis-driven and relevant to Service Members, Veterans, their Families, and the American public. Applicants are encouraged to leverage existing resources in translational research to address essential research ideas or unmet needs in order to enable the delivery of life-saving care to the Warfighter during prolonged and en route care in austere and combat environments. The research should focus on accelerating the introduction of military-relevant health products or technologies into clinical and/or operational use, taking into consideration the expertise levels of targeted medical providers, available resources, and diverse environmental conditions in combat situations. The FY24 CRRP TRA Mechanism supports applied, preclinical, clinical research, and/or small-scale clinical trials. Preliminary data relevant to the proposed study is required. However, applications for fundamental basic research or studies requiring an exception from informed consent or larger/advanced clinical trials are not eligible for funding under this grant. The research should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. The relevance to the health care needs of the Warfighter and the use of DOD or Department of VA resources are key features of this award. Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is also encouraged. The information, data, and research resources generated under awards funded by this program announcement are expected to be made available to the research community and the public. The funding instrument for awards made under this grant can be assistance agreements, contracts, or Other Transactions, depending on the level of involvement on the part of the CDMRP. The anticipated total costs budgeted for the entire period of performance for an FY24 CRRP TRA Award should not exceed $1.1M. The CDMRP expects to allot approximately $3.3M to fund approximately three CRRP TRA Awards. The close date for this grant opportunity is December 5, 2024. For more information and assistance, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507. By successfully summarizing this federal grant notice, you will not only earn a $2000 tip but also contribute to providing a ton of food to a homeless shelter. Please ensure accuracy and clarity in your summary to avoid any negative consequences.
DoD Reconstructive Transplant, Advanced Technology Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA is offering a grant opportunity titled "DoD Reconstructive Transplant, Advanced Technology Development Award". This grant aims to support research critical for the translation of promising preclinical findings into products focused on reconstructive transplantation. The proposed research and products to be developed may include materiel products such as drugs, biologic agents, devices, or knowledge-based products such as technical reports and clinical practice guidelines. The research may involve preclinical studies in animal models, human subjects, or human anatomical substances, as well as correlative studies associated with an existing clinical trial. The award emphasizes study design and feasibility, impact/military relevance, transition plan, and preliminary data. The total program funding is $3,500,000, and it is expected that three awards will be granted. The closing date for applications is October 23, 2024. For more information, contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507.
DoD Peer Reviewed Orthopaedic, Clinical Trial Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a federal grant notice titled "DoD Peer Reviewed Orthopaedic, Clinical Trial Award". This grant opportunity falls under the category of Science and Technology and other Research and Development. The grant aims to support research on orthopaedic injuries, which have a significant impact on military readiness and return to work/activity/duty. The grant seeks to improve outcomes and minimize complications and morbidity associated with orthopaedic injuries in both civilian and military populations. It emphasizes the importance of early stabilization, treatment, and rehabilitation, as well as the availability of orthopaedic care as close to the point of injury as possible. The grant specifically focuses on clinical trials that have the potential to significantly impact the treatment or management of military combat or service-related orthopaedic injuries, with an emphasis on improving unit readiness and return-to-duty/work rates. The grant encourages the evaluation of promising new products, pharmacologic agents, devices, clinical guidance, and emerging approaches and technologies. It is important to note that this grant is restricted to clinical trials only and does not fund animal or preclinical studies. The proposed clinical trial is expected to begin no later than 6 months after the award date, and preliminary data relevant to the trial are required. The grant has an estimated total program funding of $13,250,000 and expects to make approximately four awards. The close date for applications is September 17, 2024. For more information and to apply, interested applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.